KOPRAN vs SYNCOMF: Stock Comparison

KOPRAN vs SYNCOM FORMU (I)Updated 4 Sept 26, 4:08 PM ISTNSE & company filings

SYNCOM FORMU (I) is the larger company by market capitalisation. KOPRAN shows a higher dividend yield and faster revenue growth, while SYNCOM FORMU (I) shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KOPRAN leads 4; SYNCOMF leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KOPRANSYNCOMF

Valuation lens

What price are you paying?

Market CapContext only
₹1,120 Cr
₹1,933 Cr
P/E RatioSYNCOMF has the lower reading
37.34x
21.38x
P/B RatioKOPRAN has the lower reading
1.76x
4.41x
EPSKOPRAN has the higher reading
₹1.39
₹0.26
Book ValueContext only
₹109.82
₹4.41
Dividend YieldKOPRAN has the higher reading
2.76%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SYNCOMF is the larger company
₹1,933 Cr vs ₹1,120 Cr
P/E Ratio
SYNCOMF has a lower P/E
21.38x vs 37.34x
P/B Ratio
KOPRAN has a lower P/B
1.76x vs 4.41x
EPS
KOPRAN has higher earnings per share
₹1.39 vs ₹0.26
Dividend Yield
KOPRAN has a higher dividend yield
2.76% vs 0%
Revenue Growth (TTM YoY)
KOPRAN has faster revenue growth
-3.66% vs -9%
EPS Growth (TTM YoY)
SYNCOMF has faster EPS growth
68.8% vs -71.88%
Qtr Sales Growth
SYNCOMF has stronger quarterly sales growth
0.7% vs -59.25%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKOPRANSYNCOMF
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricKOPRANSYNCOMF
Live Price₹232.54₹20.58
Day Change0.13%-3.65%
Volume6.61 L1.68 Cr
52-Week High₹239.6₹22.59
52-Week Low₹107₹10.21
Distance from 52W High-2.95%-8.9%

Valuation

MetricKOPRANSYNCOMF
Market Cap₹1,120 Cr₹1,933 Cr
P/E Ratio37.34x21.38x
P/B Ratio1.76x4.41x
EPS₹1.39₹0.26
Book Value₹109.82₹4.41
Dividend Yield2.76%0%

Growth

MetricKOPRANSYNCOMF
Revenue Growth (TTM YoY)-3.66%-9%
EPS Growth (TTM YoY)-71.88%68.8%
Qtr Sales Growth-59.25%0.7%
Qtr Profit Growth0.33%1.05%

Profitability & Leverage

MetricKOPRANSYNCOMF
ROE4.85%18.43%
ROCE4.89%18.63%
Net Margin3.78%15.63%
Operating Margin6.58%20.89%
Debt to Equity0.29x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKOPRANSYNCOMF
Promoter Holding44.42%50.57%
FII Holding0.51% 0.06 pp0.35% 0.14 pp
DII Holding0%0%
Public Holding55.06% 0.06 pp49.08% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KOPRAN and SYNCOM FORMU (I).

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.